HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Repeated injection of high doses of hemoglobin-encapsulated liposomes (hemoglobin vesicles) induces accelerated blood clearance in a hemorrhagic shock rat model.

Abstract
The hemoglobin vesicle (HbV) is an artificial oxygen carrier in which a concentrated hemoglobin solution is encapsulated in a liposome. To apply liposome preparations in clinics, it is important to consider the accelerated blood clearance phenomenon (ABC phenomenon), which involves a loss in the long-circulation half-life after being administered repeatedly to the same animals. The objective of this study was to determine whether the ABC phenomenon is induced by repeated injection of HbV under conditions of hemorrhagic shock. We created a rat model of hemorrhagic shock and performed a pharmacokinetic study using (125)I-HbV, in which the Hb inside of HbV was labeled with (125)I. At 4 and 7 days after resuscitation from hemorrhagic shock by nonlabeled HbV (1400 mg Hb/kg), the second dose of (125)I-HbV (1400 mg Hb/kg) was rapidly cleared from the circulation compared with normal rats. Of interest, IgM against HbV was produced at 4 days after the first injection of HbV, but decreased at 7 days. In addition, phagocyte activity was increased at both 4 and 7 days after the first injection of HbV. These results suggest that repeated injections of HbV at a dose of 1400 mg Hb/kg induce the ABC phenomenon under conditions of hemorrhagic shock, which is strongly related to both the production of anti-HbV IgM and enhanced phagocyte activity. We thus conclude that it might be necessary to consider the ABC phenomenon in the dose regimen of HbV treatment in clinical settings.
AuthorsKazuaki Taguchi, Yasunori Iwao, Hiroshi Watanabe, Daisuke Kadowaki, Hiromi Sakai, Koichi Kobayashi, Hirohisa Horinouchi, Toru Maruyama, Masaki Otagiri
JournalDrug metabolism and disposition: the biological fate of chemicals (Drug Metab Dispos) Vol. 39 Issue 3 Pg. 484-9 (Mar 2011) ISSN: 1521-009X [Electronic] United States
PMID21123166 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Blood Substitutes
  • Hemoglobins
  • Immunoglobulin M
  • Iodine Radioisotopes
  • Liposomes
Topics
  • Animals
  • Blood Substitutes (administration & dosage, pharmacokinetics, therapeutic use)
  • Blood Volume
  • Complement Hemolytic Activity Assay
  • Drug Administration Schedule
  • Half-Life
  • Hemoglobins (administration & dosage, immunology, pharmacokinetics, therapeutic use)
  • Humans
  • Immunoglobulin M (blood)
  • Injections, Intravenous
  • Iodine Radioisotopes
  • Liposomes (administration & dosage)
  • Metabolic Clearance Rate
  • Phagocytosis (immunology)
  • Rats
  • Rats, Sprague-Dawley
  • Shock, Hemorrhagic (immunology, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: